Tekmira Pharmaceuticals Releases 2007 Audited Operating Results
Market Wire (press release) -7 hours ago
Under the January 8, 2007 license and expanded collaboration agreement with Alnylam, Tekmira received an up-front licensing payment of $9.4 million (US$8.0

More: continued here

Leave a Reply



Site Navigation